“This investment will help us bring our technology to more health care providers and ultimately improve the standard of care for patients.” “We are thrilled to have the support of the UT Austin Seed Fund, which shares our vision for improving the quality and outcomes of minimally invasive procedures,” said Dr. “We believe that providing meaningful investment is the natural extension of our myriad entrepreneurship and innovation programs, and we are excited about the company’s continued success.”ĬlearCam was born in 2018 out of a collaboration between Dell Medical School, the Cockrell School of Engineering and the Texas Innovation Center.

“ClearCam underscores the monumental impact that results when innovators from different disciplines collaborate to develop ground-breaking, commercial solutions at UT Austin,” said Christine Dixon Thiesing, associate vice president of Discovery to Impact. The device has been used in more than 1,600 procedures across the country and is gaining traction in thoracic, general and gynecologic surgeries. It enables surgeons to maintain their visual field and momentum throughout surgery, reduces a patient’s time in the OR, and maximizes surgical excellence while improving surgical safety. This is the second investment made by UT Austin’s $10 million Seed Fund.ĬlearCam’s ClearScope, a disposable in-vivo laparoscopic lens cleaner, eliminates the need for clinicians to continually remove and clean a scope during surgery. AUSTIN, Texas - Discovery to Impact at The University of Texas at Austin has invested $250,000 in ClearCam Inc., a UT-affiliated startup that has launched a technology cleared by the Food and Drug Administration that drastically improves visualization and safety in laparoscopic procedures.

Archeage war download